Thus, the decreased translational inhibition of Caveolin-1, as seen by low CSF miR-124-3p, allows for the continued activation of GSK-3β and phosphorylation of tau in AD (Kang et al., 2017). This evidence concerns the gene MAPT and Alzheimer disease.